|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Aug 02, 2012 |
Title |
F3 FICZ treated rep3 |
Sample type |
SRA |
|
|
Source name |
Hepa 1 WT cells
|
Organism |
Mus musculus |
Characteristics |
cell type: Mouse Hepatoma cell line: HC1C treatment: FICZ (10 nM) for 6 h
|
Treatment protocol |
Mouse Hepa cells were treated with vehicle control, FICZ (10 nM), or TA (50 uM) for 6 h.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was isolated using RNAeasy kit (QIAGEN, Valencia, CA). Samples were treated with de- oxyribonuclease (Invitrogen) before RNA quality control.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2000 |
|
|
Data processing |
Base conversion was done using Illumina's OLB v1.9. Mapping to mouse genome on Genomatix Mining Station with Genomatix Mapper version 3.5 Differential expression analysis on Genomatix GGA with RegionMiner program version 4.4 for transcript identification (Genomatix ElDorado database 08-2011) and DESeq (Anders & Huber, 2010) for assessment of differential expression. Expression was summarized for genes where an annotated transcript was detected as differentially expressed with an adj. P-value < 0.05 (DESeq) and a log2fold - change >1 (uregulation) or < -1 (downregulation) For assessment of Ahr induced gene expression only the profiles of upregulated genes were further used. genome build: Mus musculus NCBI build 37 Supplementary_files_format_and_content: FB_result_transcript_summary.tsv: Mapping and contrast of FICZ treatment samples / Background samples to all transcripts in Genomatix' ElDorado annotation, raw counts, normalized expression, and evaluation of differential expression by DESeq Format description (1) Supplementary_files_format_and_content: TB_result_transcript_summary.tsv: Mapping and contrast of Tryptamine treatment samples / Background samples to all transcripts in Genomatix' ElDorado annotation, raw counts, normalized expression, and evaluation of differential expression by DESeq Format description (1) Supplementary_files_format_and_content: FT_result_transcript_summary.tsv: Contrast of FICZ treatment samples / Tryptamine samples to all transcripts in Genomatix' ElDorado annotation, raw counts, normalized expression, and evaluation of differential expression by DESeq Format description (1) Supplementary_files_format_and_content: F_vs_B_up.txt: Differentially upregulated genes FICZ vs Background, summarized from the transcript data, adj. P - value < 0.05 (DESeq) and log2fold - change >1, Format description (2) Supplementary_files_format_and_content: T_vs_B_up.txt: Differentially upregulated genes Tryptamine vs Background, summarized from the transcript data, adj. P - value < 0.05 (DESeq) and log2fold - change >1, Format description (2) Supplementary_files_format_and_content: File Format(1) tab sparated text; Columns: Supplementary_files_format_and_content: 1: accession number of the transcript (e.g. RefSeq, Genbank, Ensembl) Supplementary_files_format_and_content: 2: symbol of the gene Supplementary_files_format_and_content: 3: gene ID (NCBI Entrez Gene, 0 if not available, -2 if ambiguous) Supplementary_files_format_and_content: 4: length of the transcript (sum of exons) Supplementary_files_format_and_content: 5: number of exons Supplementary_files_format_and_content: 6: p-value (DESeq) Supplementary_files_format_and_content: 7: adjusted p-value (Benjamini - Hochberg) Supplementary_files_format_and_content: 8: log2(fold change), i.e. log2(expression value of control data set / expression value of treatment data set), note, that this value can be -Inf/+Inf if one of the conditions shows no expression Supplementary_files_format_and_content: 9: Regulation of treatment (set1) compared to control (set2), (values can be "up", "down", "no") Supplementary_files_format_and_content: 10, 11, 12: number of reads for each replicate from the treatment set Supplementary_files_format_and_content: 13, 14, 15: number of reads for each replicate from the control set Supplementary_files_format_and_content: 16, 17, 18: normalized expression value for each replicate from the treatment set Supplementary_files_format_and_content: 19, 20, 21: normalized expression value for each replicate from the control set Supplementary_files_format_and_content: 22: the mean normalized expression value across the treatment replicates Supplementary_files_format_and_content: 23: the standard deviation of the normalized expression values across the treatment replicates Supplementary_files_format_and_content: 24: the mean normalized expression value across the control replicates Supplementary_files_format_and_content: 25: the standard deviation of the normalized expression values across the control replicates Supplementary_files_format_and_content: File Format(2) tab sparated text; Columns: Supplementary_files_format_and_content: 1: gene ID (NCBI Entrez Gene) Supplementary_files_format_and_content: 2: symbol of the gene Supplementary_files_format_and_content: 3: number of alternative transcripts for this gene that are up-/down-regulated regulated Supplementary_files_format_and_content: 4: total number of alternative transcripts for this gene Supplementary_files_format_and_content: 5: mean log2 fold change of up-/down-regulated transcripts Supplementary_files_format_and_content: 6: min log2 fold change of up-/down-regulated transcripts Supplementary_files_format_and_content: 7: max log2 fold change of up-/down-regulated transcripts Supplementary_files_format_and_content: 8: standard deviation across the log2 fold change values of the alternative transcripts Supplementary_files_format_and_content: 9: minimum p_value for the alternative transcripts Supplementary_files_format_and_content: 10: mean NE(treat): mean normalized expression value for the alternative transcripts in the treatment data Supplementary_files_format_and_content: 11: stddev NE(treat): standard deviation across the NE values for the alternative transcripts in the treatment data Supplementary_files_format_and_content: 12: mean NE(ctrl): mean normalized expression value for the alternative transcripts in the control data Supplementary_files_format_and_content: 13: stddev NE(ctrl): standard deviation across the NE values for the alternative transcripts in the control data Supplementary_files_format_and_content: Normalized expression/enrichment value (NE-value) The NE-value is calculated based on the following formula: NE = c * #readsregion / (#readsmapped * lengthregion) where NE is the normalized expression or enrichment value, #readsregion: the reads (sum of base pairs) of falling into either the transcript or the cluster region, #readsmapped: all mapped reads (in base pairs), lengthregion: the transcript or cluster length in base pairs and c a normalization constant set to 10E7. Except for the constant this is equivalent to RPKM
|
|
|
Submission date |
Aug 01, 2012 |
Last update date |
May 15, 2019 |
Contact name |
Bernward Klocke |
E-mail(s) |
klocke@genomatix.de
|
Organization name |
Genomatix Software GmbH
|
Street address |
Bayerstr. 85a
|
City |
Munich |
ZIP/Postal code |
D-80335 |
Country |
Germany |
|
|
Platform ID |
GPL13112 |
Series (1) |
GSE39812 |
Tryptamine Serves As a Proligand of the AhR Transcriptional Pathway, and the Activation Is Dependent of Monoamine Oxidases |
|
Relations |
SRA |
SRX172604 |
BioSample |
SAMN01096364 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|